Welcome to our dedicated page for American Shared Hospital Services news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on American Shared Hospital Services stock.
American Shared Hospital Services provides stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through equipment leasing and direct patient care services. Company news commonly covers quarterly results, procedure and treatment volumes, Gamma Knife sites, LINAC centers, proton beam radiation therapy leases, and the expansion of stand-alone radiation therapy treatment centers in the United States and Latin America.
Updates also address health system partnerships, revenue mix between leasing and direct patient services, equipment upgrades such as Gamma Knife platform improvements, and operating activity at centers including Rhode Island and Puebla, Mexico.
American Shared Hospital Services (NYSE American: AMS) reported Q3 2020 financials, revealing total revenue of $4,670,000, down 11.9% year-over-year but up 17.0% from Q2 2020. Proton therapy revenue remained flat year-over-year at $1,687,000, while Gamma Knife revenue decreased 9.9% to $2,983,000. The company experienced a net loss of $209,000, contrasting with a net income of $165,000 in Q3 2019. Notably, cash reserves increased to $3.6 million. The CEO highlighted a focus on expense management and potential growth in revenue streams.
American Shared Hospital Services (NYSE American: AMS) announced a quarterly conference call scheduled for November 12, 2020, at 3:00 pm EST. The call will discuss the company’s financial results for the third quarter of 2020, which will be released premarket on the same day. Interested parties can participate by calling 1 (888) 466-9845 and entering passcode 6465095#. The event will also be available via a simultaneous webcast on the company's website. A replay will be accessible until November 26, 2020.
American Shared Hospital Services (NYSE American: AMS) has appointed Raymond C. Stachowiak as Chief Executive Officer, effective October 1, 2020. Stachowiak has been with the company since 2009 and was serving as Interim President and CEO. Alongside this, Craig K. Tagawa becomes President and continues as Chief Operating and Financial Officer, while Ernest R. Bates is promoted to lead International Operations. The board expresses confidence in Stachowiak's leadership to drive future growth in advanced radiosurgical and radiation therapy services.
American Shared Hospital Services (AMS) reported significant financial impacts from the COVID-19 pandemic for Q2 2020. Total revenue fell by 23.2% to $3,991,000 compared to Q2 2019. While proton therapy revenue remained stable at $1,401,000, Gamma Knife revenue plummeted by 28.1% to $2,590,000. The company suffered a net loss of $483,000 versus net income of $31,000 in the previous year. Adjusted EBITDA also declined to $1,437,000. Despite challenges, AMS is seeing early signs of volume recovery in July.
American Shared Hospital Services (AMS) will hold its Annual Meeting of Shareholders virtually on June 26, 2020, at 9:00 a.m. PT, due to COVID-19. Shareholders can participate by registering online and using their unique control numbers to vote. Registration requires a legal proxy from intermediaries by June 16, 2020. The meeting's agenda and voting instructions will be accessible on the meeting site. The company remains committed to providing advanced radiation therapy solutions, including Gamma Knife and proton therapy, amidst ongoing uncertainties from the pandemic.
American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call on May 11, 2020, at 3:00pm EDT to discuss its first quarter 2020 financial results. The results will be released premarket on the same day. Interested participants can join the call by dialing 1 (877) 420-2982 and entering passcode 9311758#. A simultaneous webcast will be accessible via the company's website. A playback of the call will be available until June 10, 2020, using passcode 49677167.